For sale: Amgen chops 60% off Repatha's $14,520 retail price

24th October 2018 Uncategorised 0

It’s common for drugmakers to offer behind-the-scenes rebates and discounts to win coverage for their drugs. But cut list prices? That’s far more rare. Amgen, though, is doing just that with its PCSK9 cholesterol drug, whose highly anticipated launch was weighed down by its price tag.

More: For sale: Amgen chops 60% off Repatha's ,520 retail price
Source: fierce